Journal rankings · indicator year 2014
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2014
Infectious Diseases journal rankings 2014
173 ranked journals · Subfield in Medicine
Infectious Diseases has 173 ranked journals in 2014. The median journal has an OJR of 0.91, below the world average of 1.00, up 0.01 on 2013; Q1 starts at OJR 1.40. The top three are New England Journal of Medicine, Clinical Microbiology Reviews, and PLoS Medicine.
Ranks and citation indicators: 2014. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2011–2013, the window the 2014 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery734
- Pulmonary and Respiratory Medicine283
- Public Health, Environmental and Occupational Health244
- Cardiology and Cardiovascular Medicine227
- Oncology179
- Infectious Diseases173
- Epidemiology166
- Neurology138
- Endocrinology, Diabetes and Metabolism136
- Radiology, Nuclear Medicine and Imaging136
- Physiology127
- Psychiatry and Mental health119
Show all 42 subfields
- Orthopedics and Sports Medicine89
- Pediatrics, Perinatology and Child Health80
- Ophthalmology75
- Dermatology74
- Hematology69
- Rheumatology59
- Obstetrics and Gynecology58
- Nephrology51
- Pharmacology43
- Reproductive Medicine43
- Complementary and alternative medicine41
- Emergency Medicine36
- Geriatrics and Gerontology35
- Otorhinolaryngology34
- Rehabilitation25
- Critical Care and Intensive Care Medicine22
- Pathology and Forensic Medicine21
- Genetics19
- Hepatology18
- Immunology and Allergy16
- Anesthesiology and Pain Medicine12
- Urology12
- Gastroenterology6
- Internal Medicine5
- Transplantation3
- Family Practice2
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
173 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2013. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2011–2013, the window the 2014 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2011–2013 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2005 to 2014. | Compare |
|---|---|---|---|---|---|---|---|
1New England Journal of MedicineMassachusetts Medical Society · United States | 14.34Q1 | 28.92 1.32 up from 2013 | 2,879 | 39% | — | ||
2Clinical Microbiology ReviewsAmerican Society for Microbiology · United States | 11.98Q1 | 24.92 1.87 up from 2013 | 97 | 98% | — | ||
3PLoS MedicineOAPublic Library of Science · United States | 5.30Q1 | 11.69 0.40 down from 2013 | 629 | 100% | $6,460 | ||
4Annals of Internal MedicineAmerican College of Physicians · United States | 4.27Q1 | 8.82 0.27 up from 2013 | 1,303 | 11% | — | ||
5The Lancet Infectious DiseasesElsevier BV · Netherlands | 4.02Q1 | 9.94 0.32 up from 2013 | 639 | 42% | $7,280 | ||
6PLoS PathogensOAPublic Library of Science · United States | 3.97Q1 | 9.39 0.42 down from 2013 | 1,934 | 100% | $3,043 | ||
7Clinical Infectious DiseasesOxford University Press · United States | 3.50Q1 | 8.11 0.51 down from 2013 | 2,047 | 49% | $4,763 | ||
8The Lancet Global HealthOAElsevier BV · Netherlands | 3.15Q1 | 4.32no 2013 value | 101 | 100% | $6,680 | — | |
9EurosurveillanceOAEuropean Centre for Disease Prevention and Control · Sweden | 2.68Q1 | 6.62 1.09 up from 2013 | 652 | 100% | — | ||
10The Journal of Infectious DiseasesOxford University Press · United States | 2.57Q1 | 6.07 0.13 up from 2013 | 2,015 | 61% | $4,763 | ||
11Clinical Microbiology and InfectionElsevier BV · United Kingdom | 2.57Q1 | 5.65 0.45 down from 2013 | 929 | 95% | $3,780 | ||
12Emerging infectious diseasesOACenters for Disease Control and Prevention · United States | 2.37Q1 | 5.37 0.37 up from 2013 | 1,787 | 100% | — | ||
13VirulenceOATaylor & Francis · United States | 2.32Q1 | 5.08 1.18 up from 2013 | 264 | 100% | $2,557 | ||
14The Indian Journal of Medical ResearchOAMedknow · India | 2.21Q1 | 5.72 0.50 up from 2013 | 93 | 100% | — | ||
15Reviews in Medical VirologyWiley · United Kingdom | 2.14Q1 | 5.17 0.67 down from 2013 | 101 | 21% | $4,880 | ||
16AIDSLippincott Williams & Wilkins · United Kingdom | 2.07Q1 | 5.03 0.62 down from 2013 | 1,144 | 49% | — | ||
17VirusesOAMultidisciplinary Digital Publishing Institute · Switzerland | 2.03Q1 | 4.73 0.27 up from 2013 | 503 | 100% | $3,137 | ||
18Journal of Antimicrobial ChemotherapyOxford University Press · United Kingdom | 1.98Q1 | 5.24 0.16 down from 2013 | 1,636 | 43% | $3,784 | ||
19International Journal of Medical MicrobiologyOAElsevier BV · Germany | 1.96Q1 | 4.17 0.25 up from 2013 | 229 | 24% | $3,410 | ||
20Current Opinion in HIV and AIDSLippincott Williams & Wilkins · United Kingdom | 1.95Q1 | 5.69 0.74 up from 2013 | 251 | 54% | — | ||
21Future MicrobiologyFuture Medicine · United Kingdom | 1.91Q1 | 4.38 0.43 up from 2013 | 389 | 18% | — | ||
22Journal of Clinical MicrobiologyOAAmerican Society for Microbiology · United States | 1.89Q1 | 4.55 0.08 down from 2013 | 2,517 | 99% | — | ||
23Antiviral ResearchElsevier BV · Netherlands | 1.88Q1 | 4.86 1.16 up from 2013 | 605 | 38% | $4,160 | ||
24Antimicrobial Agents and ChemotherapyOAAmerican Society for Microbiology · United States | 1.86Q1 | 4.97 0.10 down from 2013 | 2,932 | 100% | — | ||
25Current HIV/AIDS ReportsSpringer Science+Business Media · United States | 1.80Q1 | 5.07 0.12 up from 2013 | 116 | 54% | $4,190 | ||
26AIDS and BehaviorSpringer Science+Business Media · Netherlands | 1.73Q1 | 3.98 0.26 up from 2013 | 796 | 79% | $4,590 | ||
27AnaerobeElsevier BV · United Kingdom | 1.73Q1 | 3.20 0.12 down from 2013 | 345 | 14% | $3,350 | ||
28BMC Infectious DiseasesOABioMed Central · United Kingdom | 1.71Q1 | 3.82 0.10 up from 2013 | 1,358 | 100% | $3,090 | ||
29JAIDS Journal of Acquired Immune Deficiency SyndromesLippincott Williams & Wilkins · United States | 1.68Q1 | 4.19 0.09 down from 2013 | 1,189 | 55% | — | ||
30Journal of the International AIDS SocietyOAInternational AIDS Society · United States | 1.64Q1 | 3.68 0.48 up from 2013 | 344 | 100% | $2,600 | ||
31Journal of General VirologyMicrobiology Society · United Kingdom | 1.62Q1 | 3.69 0.24 down from 2013 | 905 | 37% | — | ||
32Infection Control and Hospital EpidemiologyCambridge University Press · United Kingdom | 1.61Q1 | 3.53 0.67 up from 2013 | 1,010 | 50% | $3,550 | ||
33British Journal of Clinical PharmacologyWiley · United Kingdom | 1.58Q1 | 3.60 0.43 up from 2013 | 806 | 95% | $4,780 | ||
34FEMS Immunology & Medical MicrobiologyOxford University Press · Netherlands | 1.57Q1 | 4.54 1.54 up from 2013 | 256 | — | — | ||
35Antimicrobial Resistance and Infection ControlOABioMed Central · United Kingdom | 1.57Q1 | 3.34 0.29 up from 2013 | 91 | 100% | $3,290 | ||
36The Open Microbiology JournalOABentham Science Publishers · Netherlands | 1.56Q1 | 2.68 0.10 up from 2013 | 60 | 100% | — | ||
37Virus ResearchOAElsevier BV · Netherlands | 1.56Q1 | 2.74 0.55 down from 2013 | 823 | 30% | $3,010 | ||
38AIDS Education and PreventionGuilford Press · United States | 1.54Q1 | 2.60 0.02 up from 2013 | 138 | 53% | — | ||
39Infection Genetics and EvolutionOAElsevier BV · Netherlands | 1.53Q1 | 3.29 0.55 down from 2013 | 914 | 27% | $2,730 | ||
40Microbes and InfectionElsevier BV · France | 1.50Q1 | 2.85 0.47 down from 2013 | 415 | 99% | $3,510 | ||
41Expert Review of Anti-infective TherapyTaylor & Francis · United Kingdom | 1.46Q1 | 3.43 0.54 up from 2013 | 432 | 33% | — | ||
42Journal of InfectionOAElsevier BV · United Kingdom | 1.44Q1 | 3.62 0.41 up from 2013 | 581 | 20% | $4,030 | ||
43HIV MedicineWiley · United Kingdom | 1.42Q1 | 3.40 0.16 down from 2013 | 313 | 55% | $4,150 | ||
44Emerging Microbes & InfectionsOATaylor & Francis · United Kingdom | 1.40Q1 | 3.19 1.11 up from 2013 | 70 | 100% | $2,643 | ||
45AIDS Patient Care and STDsMary Ann Liebert, Inc. · United States | 1.37Q2 | 3.90 0.16 down from 2013 | 300 | 72% | — | ||
46Journal of PathogensHindawi Publishing Corporation · United Kingdom | 1.34Q2 | 2.65 0.25 up from 2013 | 49 | 100% | $950 | ||
47AIDS CareTaylor & Francis · United Kingdom | 1.33Q2 | 2.54 0.33 down from 2013 | 760 | 49% | — | ||
48Tropical Medicine & International HealthWiley · United Kingdom | 1.33Q2 | 2.69 0.04 down from 2013 | 579 | 61% | $3,400 | ||
49Medical Microbiology and ImmunologySpringer Science+Business Media · Germany | 1.31Q2 | 3.36 0.93 up from 2013 | 137 | 32% | $5,090 | ||
50Virology JournalOABioMed Central · United Kingdom | 1.29Q2 | 3.03 0.14 up from 2013 | 1,241 | 100% | $3,290 |
Subfields of Medicine, with Infectious Diseases highlighted.
- Surgery734
- Pulmonary and Respiratory Medicine283
- Public Health, Environmental and Occupational Health244
- Cardiology and Cardiovascular Medicine227
- Oncology179
- Infectious Diseases173
- Epidemiology166
- Neurology138
- Endocrinology, Diabetes and Metabolism136
- Radiology, Nuclear Medicine and Imaging136
- Physiology127
- Psychiatry and Mental health119
- Orthopedics and Sports Medicine89
- Pediatrics, Perinatology and Child Health80
- Ophthalmology75
- Dermatology74
- Hematology69
- Rheumatology59
- Obstetrics and Gynecology58
- Nephrology51
- Pharmacology43
- Reproductive Medicine43
- Complementary and alternative medicine41
- Emergency Medicine36
- Geriatrics and Gerontology35
- Otorhinolaryngology34
- Rehabilitation25
- Critical Care and Intensive Care Medicine22
- Pathology and Forensic Medicine21
- Genetics19
- Hepatology18
- Immunology and Allergy16
- Anesthesiology and Pain Medicine12
- Urology12
- Gastroenterology6
- Internal Medicine5
- Transplantation3
- Family Practice2
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2014. Corpus-wide, 77.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
40 additional Infectious Diseases journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2011–2013, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2014. Publication window: 2011–2013. How these summaries are calculated
- Ranked journals
- 173
- Window papers (baseline)
- 58,513 +18.2% from indicator year 2011
- Median OJR
- 0.91 -9.3% from indicator year 2011
- Rising journals (2025)
- 48
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2011–2013 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 70 | 73 | 78 | 82 | 86 | 92 | 95 | 101 | 106 | 110 | 118 | 131 | 144 | 162 | 173 | 182 | 189 | 198 | 210 | 217 | 222 | 234 | 243 | 259 | 263 | 258 | |
| Window papers (baseline) | 18,375 | 21,167 | 22,805 | 24,640 | 25,208 | 28,008 | 31,333 | 35,063 | 38,170 | 42,272 | 46,364 | 49,515 | 52,080 | 54,445 | 58,513 | 62,728 | 67,259 | 69,548 | 70,742 | 70,658 | 72,743 | 100,768 | 135,954 | 162,915 | 153,103 | 130,899 | |
| Median OJR | 0.602 | 0.68 | 0.82 | 0.76 | 0.77 | 0.901 | 0.98 | 0.93 | 1.04 | 0.998 | 1.01 | 0.999 | 0.97 | 0.900 | 0.91 | 0.874 | 0.85 | 0.8699 | 0.8696 | 0.83 | 0.80 | 0.597 | 0.61 | 0.64 | 0.70 | 0.75 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.